LAV Biosciences Fund IV, L.P. Lilly Asia Ventures

LAVVINTAGE 2017

NET IRR

12.6%

TVPI

1.66x

DPI

0.85x

COMMITMENT

$40M

LP SOURCES

1

CROSS-REFERENCE TABLE

LP SOURCE	AS OF	COMMITMENT	PAID IN	NET IRR	TVPI	DPI	DOC
LACERA	2025-03-31	$40M	$47.1M	12.6%	1.66x	0.85x	SOURCE ↗◆